Pembrolizumab in patients with programmed death ligand 1–positive advanced ovarian cancer: Analysis of KEYNOTE-028
Varga, Andrea, Piha-Paul, Sarina, Ott, Patrick A., Mehnert, Janice M., Berton-Rigaud, Dominique, Morosky, Anne, Yang, Ping, Ruman, Jane, Matei, DanielaLanguage:
english
Journal:
Gynecologic Oncology
DOI:
10.1016/j.ygyno.2018.11.017
Date:
December, 2018
File:
PDF, 541 KB
english, 2018